MBZUAI and BioMap have signed an MoU to establish the first biocomputing innovation research lab in the Middle East, located on MBZUAI's campus. The collaboration will focus on applying AI protein generation to life science models, addressing needs in drug design, energy, and environmental protection. The lab will research de novo design of oil degradation enzymes and identify drug targets for aging-associated and rare diseases. Why it matters: This partnership signals a growing focus on applying AI to critical life science challenges in the region, potentially leading to breakthroughs in drug discovery and sustainable energy solutions.
MBZUAI has announced partnerships with IBT and BioMap to advance AI applications in healthcare. The collaboration with IBT will focus on developing personalized digital therapeutics for brain health. The partnership with BioMap will establish a biocomputing innovation research lab in the Middle East focused on AI-generated proteins. Why it matters: These partnerships highlight MBZUAI's commitment to leveraging AI for personalized healthcare solutions and establishing the UAE as a hub for biocomputing innovation.
MBZUAI hosted a Single Cell Summer Workshop, gathering over 25 participants and speakers to explore single-cell omics data. The two-day event featured three workshops, nine talks, and networking opportunities, aiming to develop bioinformatics skills and strengthen the regional ecosystem. Workshops were led by Eduardo Beltrame (MBZUAI), Mariano Gabitto (Allen Institute), and Luke Zappia (Data Intuitive), covering topics like scvi-tools, multimodal machine learning, and benchmarking. Why it matters: This workshop signifies MBZUAI's commitment to advancing bioinformatics research in the UAE and fostering collaboration within the regional scientific community.
MBZUAI has launched master’s and Ph.D. programs in computational biology, expanding its research into life sciences. This includes projects like AIDO (AI-Driven Digital Organism) and analysis of the Emirati Genome Program. The programs are part of MBZUAI’s School of Digital Public Health and aim to integrate computational biology with precision medicine. Why it matters: This initiative supports the UAE's vision for a knowledge-based economy and its ambition to become a global center for scientific and technological progress in biotechnology and healthcare.
MBZUAI and the Department of Health – Abu Dhabi (DoH) have signed an agreement to collaborate on AI research across genomics, precision medicine, robotics, and AI-powered diagnostics. Signed on October 13, 2025, the MoU aims to drive breakthroughs in disease prevention, early detection, and therapeutics. The partnership seeks to translate AI research into tangible improvements in patient care within Abu Dhabi and beyond. Why it matters: This partnership signifies a major push to establish Abu Dhabi as a leader in biomedical research and AI-driven healthcare innovation.